Method for treatment of insulin resistance in obesity and diabetes
CA 2422068 A1 · Owner: Oklahoma Medical Research Foundation · Inventors: Hochgeschwender, Ute; Brennan, Miles B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is a method to identify compounds useful for reducing insulin resistance is a patient, and particularly a patient that has insulin resistance associated with obesity and/or type II diabetes. Also disclosed is a method of reducing insulin resistance in a patient by administering a compound identified using the method of the invention and particularly, by , administering an antagonist of melanocortin stimulating hormone (MSH) biological activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.